Luis Moroder

Last updated

Luis Moroder
LuisMoroder.jpg
Luis Moroder in 2017
Born (1940-12-06) 6 December 1940 (age 82)
Nationality Italian
Alma mater University of Padova, University of Pittsburgh, Technical University of Munich
Scientific career
Fields Peptide chemistry, bioorganic chemistry, biophysical chemistry
Institutions Max Planck Institute for Biochemistry

Luis Moroder (born 6 December 1940) is an Italian peptide chemist, who pioneered research on the interactions between peptide hormones and cell membrane-bound hormone receptors. He later expanded this research to other biological systems of medical relevance such as protein inhibitors, collagens, and synthetic proteins. A hallmark of his research is interdisciplinarity as reflected in his use and development of methods in organic chemistry, biophysics and molecular biology. He is a co-editor of the five-volume Houben-Weyl, Methods of Organic Chemistry, Synthesis of Peptides and Peptidomimetics. Since 2008 he is the editor-in-chief of the Journal of Peptide Science , the official journal of the European Peptide Society. [1]

Contents

Early life, education and career

Moroder studied chemistry at the University of Padova, where he graduated 1965 in chemistry with the doctoral thesis on synthesis of S-peptide of ribonuclease A in the laboratory of Ernesto Scoffone at the Institute of Organic Chemistry. [2] In 1968 he joined Klaus H. Hofmann's Group at the University of Pittsburgh to work on chemical synthesis of the peptidic adrenocorticotropic hormone and its derivatives. [3] Moroder habilitated in 1971 at the University of Padova in Chemistry of Natural Products. 1975 he became a senior research fellow in the Department of Peptide Chemistry at the Max Planck Institute for Biochemistry (MPIB) in Martinsried headed by Erich Wünsch  [ de ]. Between 1991 and 2008 he was the head of the Laboratory of Bioorganic chemistry at the MPIB. [1] Since 1994 he is an adjunct professor at the Technical University of Munich.

Research

Moroder has started his peptide research with the synthesis of the S-peptide of ribonuclease A and studies on this protein-peptide complex. It was one of the first demonstrations of the key and lock principle in peptide hormone receptor interactions. [4] As research associate he worked on the synthesis of radioactive adrenocorticotropin, which represents one of the first synthetic research works on human peptide hormones. [3] Moroder's work at the Max Planck Institute for Biochemistry in Martinsried was initially focused on the gastrin/cholecystokinin system, revealing the mechanism for the membrane-bound pathway of hormone recognition by the receptors. [5] In parallel, he worked on synthetic methods in peptide and protein chemistry such as the introduction of di-tert-butyl dicarbonate as a general and widely used reagent in peptide chemistry, [6] regioselective assembly of cystine-rich peptides, [7] and the synthesis of highly robust disulfide/diselenide scaffolds. [8]

In the later phase of his research, Moroder became increasingly interested in the study of more complex biological and medical systems by chemical means. For example, he addressed fundamental questions of the kinetics of protein folding [9] and actively contributed to the design and synthesis of enzyme inhibitors involved in various diseases, including cancer. [10] In the 1990s Luis Moroder and Robert Huber supported Nediljko Budisa in establishing genetic code engineering in Germany - a research area that merges chemical syntheses with biological complexities in the form of chemical synthetic biology (Xenobiology). [11] [12]

Awards and honors (selection)

Personal life

Luis Moroder grew up in the small ethnic community of Ladins in the Dolomites of South Tyrol/Northern Italy. As a boy he became fascinated by natural science while accompanying his father Heinrich on mineralogical, paleontological and archaeological excursions in the mountain world of his homeland with discoveries of various fossiles that are exemplary shown in the Museum Gherdeina. He is married to Anne Marie Hellrigl-Moroder with one daughter.

Related Research Articles

<span class="mw-page-title-main">Proteolysis</span> Breakdown of proteins into smaller polypeptides or amino acids

Proteolysis is the breakdown of proteins into smaller polypeptides or amino acids. Uncatalysed, the hydrolysis of peptide bonds is extremely slow, taking hundreds of years. Proteolysis is typically catalysed by cellular enzymes called proteases, but may also occur by intra-molecular digestion.

Combinatorial chemistry comprises chemical synthetic methods that make it possible to prepare a large number of compounds in a single process. These compound libraries can be made as mixtures, sets of individual compounds or chemical structures generated by computer software. Combinatorial chemistry can be used for the synthesis of small molecules and for peptides.

Choh Hao Li was a Chinese-born American biochemist who discovered, in 1966, that human pituitary growth hormone (somatotropin) consists of a chain of 256 amino acids. In 1970 he succeeded in synthesizing this hormone, the largest protein molecule synthesized up to that time.

<span class="mw-page-title-main">Robert Bruce Merrifield</span> American biochemist

Robert Bruce Merrifield was an American biochemist who won the Nobel Prize in Chemistry in 1984 for the invention of solid phase peptide synthesis.

<span class="mw-page-title-main">Peptide synthesis</span> Production of peptides

In organic chemistry, peptide synthesis is the production of peptides, compounds where multiple amino acids are linked via amide bonds, also known as peptide bonds. Peptides are chemically synthesized by the condensation reaction of the carboxyl group of one amino acid to the amino group of another. Protecting group strategies are usually necessary to prevent undesirable side reactions with the various amino acid side chains. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide (C-terminus), and proceeds toward the amino-terminus (N-terminus). Protein biosynthesis in living organisms occurs in the opposite direction.

Xenobiology (XB) is a subfield of synthetic biology, the study of synthesizing and manipulating biological devices and systems. The name "xenobiology" derives from the Greek word xenos, which means "stranger, alien". Xenobiology is a form of biology that is not (yet) familiar to science and is not found in nature. In practice, it describes novel biological systems and biochemistries that differ from the canonical DNA–RNA-20 amino acid system. For example, instead of DNA or RNA, XB explores nucleic acid analogues, termed xeno nucleic acid (XNA) as information carriers. It also focuses on an expanded genetic code and the incorporation of non-proteinogenic amino acids into proteins.

Chemical biology is a scientific discipline between the fields of chemistry and biology. The discipline involves the application of chemical techniques, analysis, and often small molecules produced through synthetic chemistry, to the study and manipulation of biological systems. In contrast to biochemistry, which involves the study of the chemistry of biomolecules and regulation of biochemical pathways within and between cells, chemical biology deals with chemistry applied to biology.

Stephen B. H. Kent is a chemistry professor at the University of Chicago. While professor at the Scripps Research Institute in the early 1990s he pioneered modern ligation methods for the total chemical synthesis of proteins. He was the inventor of native chemical ligation together with his student Philip Dawson. His laboratory experimentally demonstrated the principle that chemical synthesis of a protein's polypeptide chain using mirror-image amino acids after folding results in a mirror-image protein molecule which, if an enzyme, will catalyze a chemical reaction with mirror-image stereospecificity. At the University of Chicago Kent and his junior colleagues pioneered the elucidation of protein structures by quasi-racemic & racemic crystallography.

<i>tert</i>-Butyloxycarbonyl protecting group Protecting group used in organic synthesis

The tert-butyloxycarbonyl protecting group or tert-butoxycarbonyl protecting group is a protecting group used in organic synthesis.

Melanocortin receptors are members of the rhodopsin family of 7-transmembrane G protein-coupled receptors.

<span class="mw-page-title-main">Ronald T. Raines</span>

Ronald T. Raines is an American chemical biologist. He is the Roger and Georges Firmenich Professor of Natural Products Chemistry at the Massachusetts Institute of Technology. He is known for using ideas and methods of physical organic chemistry to solve important problems in biology.

{{Infobox scientist | name = Max Bergmann | image = | caption = | birth_date = 12 February 1886 | birth_place = Fürth, Germany | nationality = | death_date = 7 November 1944 (aged 58) | death_place = New York City, United States | field = peptide chemistry | work_institution = Kaiser Wilhelm Institute for Leather Research
Rockefeller Institute for Medical Research | alma_mater = Ludwig Maximilian University of Munich, Friedrich Wilhelm University | doctoral_advisor = Ignaz Bloch | doctoral_students = Leonidas Zervas | known_for = Carboxybenzyl protecting group | spouse = Emmy Bergmann [[:de:Emmy Bergmann | children = Peter Bergmann (physicist) }} Max Bergmann was a Jewish-German biochemist. Together with Leonidas Zervas, the discoverer of the group, they were the first to use the carboxybenzyl protecting group for the synthesis of oligopeptides.

<span class="mw-page-title-main">Cholecystokinin A receptor</span> Protein-coding gene in the species Homo sapiens

The Cholecystokinin A receptor is a human protein, also known as CCKAR or CCK1, with CCK1 now being the IUPHAR-recommended name.

<span class="mw-page-title-main">Melanin-concentrating hormone receptor 2</span> Protein-coding gene in the species Homo sapiens

Melanin-concentrating hormone receptor 2 (MCH2) also known as G-protein coupled receptor 145 (GPR145) is a protein that in humans is encoded by the MCHR2 gene.

Joseph Stewart Fruton, born Joseph Fruchtgarten, was a Polish-American biochemist and historian of science. His most significant scientific work involved synthetic peptides and their interactions with proteases; with his wife Sofia Simmonds he also published an influential textbook, General Biochemistry. From 1970 until his death, Fruton worked extensively on the history of science, particularly the history of biochemistry and molecular biology.

<span class="mw-page-title-main">Klaus H. Hofmann</span> American chemist (1911 - 1995)

Klaus H. Hofmann was an American biological chemist and medical researcher. The New York Times called Hofmann an "expert on synthesis of body compounds". His career was highlighted by synthesis of a prototype birth control pill, isolation and structural characterization of biotin, determination of the lysine specificity of the pancreatic protease trypsin, the first chemical synthesis of a fully biologically-active portion of the peptide hormone, and structure-function studies on ribonuclease (RNase).

<span class="mw-page-title-main">Nediljko Budisa</span>

Nediljko "Ned" Budisa is a Croatian biochemist, professor and holder of the Tier 1 Canada Research Chair (CRC) for chemical synthetic biology at the University of Manitoba. As pioneer in the areas of genetic code engineering and chemical synthetic biology (Xenobiology), his research has a wide range of applications in biotechnology and engineering biology in general. Being highly interdisciplinary, it includes bioorganic and medical chemistry, structural biology, biophysics and molecular biotechnology as well as metabolic and biomaterial engineering. He is the author of the only textbook in his research field: “Engineering the genetic code: expanding the amino acid repertoire for the design of novel proteins”.

<span class="mw-page-title-main">Günther Jung</span> German chemist

Günther Jung is a German chemist. He was professor for Organic Chemistry and Biochemistry at the University of Tübingen from 1973 to 2002.

Peptide therapeutics are peptides or polypeptides which are used to for the treatment of diseases. Naturally occurring peptides may serve as hormones, growth factors, neurotransmitters, ion channel ligands, and anti-infectives; peptide therapeutics mimic such functions. Peptide Therapeutics are seen as relatively safe and well-tolerated as peptides can be metabolized by the body.

Leonidas Zervas was a Greek organic chemist who made seminal contributions in peptide chemical synthesis. Together with his mentor Max Bergmann they laid the foundations for the field in 1932 with their major discovery, the Bergmann-Zervas carboxybenzoxy oligopeptide synthesis which remained unsurpassed in utility for the next two decades. The carboxybenzyl protecting group he discovered is often abbreviated Z in his honour.

References

  1. 1 2 "Luis Moroder | Max Planck Institute of Biochemistry". Max Planck Institute. Retrieved August 20, 2021.
  2. 1 2 "Detailed CV - cv_moroder.pdf" (PDF). Max Planck Institute. Retrieved August 20, 2021.
  3. 1 2 Moroder, L.; Hofmann, K. (1970). "Studies on polypeptides. XLVI. Synthesis of a stably labeled, biologically active adrenocorticotropin fragment". J Med Chem. 13 (5): 839–843. doi:10.1021/jm00299a010. PMID   4318767.
  4. Moroder, L.; Borin, G.; Marchiori, F.; Rocchi, R.; Scoffone, E. (1973). "Kinetic and physical chemical studies on partially synthetic ribonuclease S-analogs". Peptides 1971, Proc. XIth Europ. Peptide Symposium. Amsterdam: North Holland. pp. 367–372.
  5. Moroder, L.; Romano, R.; Guba, W.; Mierke, D. F.; Kessler, H.; Delporte, C.; Winand, J.; Christophe, J. (1993). "New evidence for a membrane-bound pathway in hormone receptor binding". Biochemistry. 32 (49): 13551–13559. doi:10.1021/bi00212a022. PMID   7504952.
  6. Moroder, L.; Hallett, A.; Wünsch, E.; Keller, O.; Wersin, G. (1976). "Di-tert-Butyldicarbonat: ein vorteilhaftes Reagenz zur Einführung der tert-Butyloxycarbonyl-Schutzgruppe" [Di-tert-butyl-dicarbonate, a useful tert-butyloxycarbonylating reagent]. Hoppe-Seyler's Z. Physiol. Chem. 357 (11): 1651–1653. doi:10.1515/bchm2.1976.357.2.1651. PMID   1002132.
  7. Moroder, L.; Musiol, H.-J.; Götz, M.; Renner, C. (2005). "Synthesis of single- and multiple-stranded cystine-rich peptides". Biopolymers. 80 (2–3): 85–97. doi: 10.1002/bip.20174 . PMID   15612050. S2CID   3213208.
  8. Besse, D.; Siedler, F.; Diercks, T.; Kessler, H.; Moroder, L. (1997). "The redox potential of selenocystine in unconstrained cyclic peptides". Angew. Chem. Int. Ed. 36 (8): 883–885. doi: 10.1002/anie.199708831 .
  9. Bredenbeck, J.; Helbing, J.; Sieg, A.; Schrader, T.; Zinth, W.; Wachtveitl, J.; Renner, C.; Behrendt, R.; Moroder, L.; Hamm, P. (2003). "Picosecond conformational transition and equilibration of a cyclic peptide". Proc. Natl. Acad. Sci. USA. 100 (11): 6452–6457. Bibcode:2003PNAS..100.6452B. doi: 10.1073/pnas.1036583100 . PMC   164467 . PMID   12736378.
  10. Loidl, G.; Groll, M.; Musiol, H.-J.; Huber, R.; Moroder, L. (1999). "Bivalency as a principle for proteasome inhibition". Proc. Natl. Acad. Sci. USA. 96 (10): 5418–5422. Bibcode:1999PNAS...96.5418L. doi: 10.1073/pnas.96.10.5418 . PMC   21874 . PMID   10318898.
  11. Budisa, N.; Minks, C.; Medrano, F. J.; Lutz, J.; Huber, R.; Moroder, L. (1998). "Residue-specific bioincorporation of non-natural, biologically active amino acids into proteins as possible drug carriers: structure and stability of the per-thiaproline mutant of annexin V". Proc. Natl. Acad. Sci. USA. 95 (2): 455–459. Bibcode:1998PNAS...95..455B. doi: 10.1073/pnas.95.2.455 . PMC   18441 . PMID   9435213.
  12. Moroder, L.; Budisa, N. (2010). "Synthetic biology of protein folding". ChemPhysChem. 11 (6): 1181–1187. doi:10.1002/cphc.201000035. PMID   20391526.
  13. "Max-Bergmann-Medaille - Max Bergmann Kreis e.V." Max Bergmann Kreis e.V. Retrieved August 20, 2021.
  14. "Josef Rudinger Memorial Award - European Peptide Society". European Peptide Society. May 18, 2016. Retrieved August 20, 2021.
  15. "Akabori Memorial Award | The Japanese Peptide Society". Japanese Peptide Society. Retrieved August 20, 2021.
  16. "Votazioni on line, Premio Scoffone per l'anno 2020: estensione voto al 20 Aprile 2020". Italian Peptide Society. Retrieved August 20, 2021.